Li, R.; Duan, L.; Sun, S.; Li, D.; Peng, Q.; Shang, Y.
Sulbactam–Durlobactam in the Treatment of Bloodstream Infection Due to Carbapenem-Resistant Acinetobacter baumannii: A Case Series and Literature Review. J. Clin. Med. 2026, 15, 2281.
https://doi.org/10.3390/jcm15062281
AMA Style
Li R, Duan L, Sun S, Li D, Peng Q, Shang Y.
Sulbactam–Durlobactam in the Treatment of Bloodstream Infection Due to Carbapenem-Resistant Acinetobacter baumannii: A Case Series and Literature Review. Journal of Clinical Medicine. 2026; 15(6):2281.
https://doi.org/10.3390/jcm15062281
Chicago/Turabian Style
Li, Ruiting, Limin Duan, Shengwen Sun, Dan Li, Qiwei Peng, and You Shang.
2026. "Sulbactam–Durlobactam in the Treatment of Bloodstream Infection Due to Carbapenem-Resistant Acinetobacter baumannii: A Case Series and Literature Review" Journal of Clinical Medicine 15, no. 6: 2281.
https://doi.org/10.3390/jcm15062281
APA Style
Li, R., Duan, L., Sun, S., Li, D., Peng, Q., & Shang, Y.
(2026). Sulbactam–Durlobactam in the Treatment of Bloodstream Infection Due to Carbapenem-Resistant Acinetobacter baumannii: A Case Series and Literature Review. Journal of Clinical Medicine, 15(6), 2281.
https://doi.org/10.3390/jcm15062281
